| Makale Türü |
|
||
| Dergi Adı | Tohoku Journal of Experimental Medicine | ||
| Dergi ISSN | 0040-8727 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SSCI | ||
| Makale Dili | İngilizce | Basım Tarihi | 12-2003 |
| Kabul Tarihi | 12-04-2026 | Yayınlanma Tarihi | – |
| Cilt / Sayı / Sayfa | 201 / 4 / 221–228 | DOI | 10.1620/tjem.201.221 |
| Makale Linki | http://joi.jlc.jst.go.jp/JST.JSTAGE/tjem/201.221?from=CrossRef | ||
| Özet |
| MATERIALSAND METHODSA totalof71patients (37ofthem males, and34females) whoreferredtotheDepartment ofInfectiousDiseasesintheMedicalFacultyof YuzuncuYılUniversitybetweenMarch1997 andDecember2001, withahistoryofthedisease forabout1 yearormore, diagnosed with chronic brucellosis through brucella serum agglutinationtest (SAT) andSATwithCoombs anddetectionofIgG antibodiesbySAT with 2-mercaptoethanol (2-MESAT) wereenrolledin thestudy. Thepatientswererandomlydivided intolevamisolegroup (36patients) andcontrol group (35patients). Allpatients were given rifampin600mg/day+ doxycycline200mg/dayfor6weeksasastandardclassicalcombinedtherapyforbrucellosis. Inthelevamisole group, orallevamisole80mgeveryotherday for6weekswasaddedtothetreatment. The informed consent was taken from allthe patientsinlevamisolegroupaftertheyhave beeninformedaboutthetreatmentbasedonthe decisionoftheInfectiousDiseasesAcademic Committeewhichapprovedthestudy (thedecisiondate: 18February1997, number: 7). Clinicalandlaboratorycontrolsofbothgroupswere performedonattheendof6weeks, 3months and6months. |
| Anahtar Kelimeler |
| Chronic brucellosis | Levamisole | Treatment |
| Atıf Sayıları | |
| Google Scholar | 37 |
| Web of Science | 17 |
| Dergi Adı | TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE |
| Yayıncı | Tohoku University Medical Press |
| Açık Erişim | Hayır |
| ISSN | 0040-8727 |
| E-ISSN | 1349-3329 |
| CiteScore | 2,8 |
| SJR | 0,460 |
| SNIP | 0,475 |